Viewing Study NCT03179904


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-01-11 @ 7:26 AM
Study NCT ID: NCT03179904
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-16
First Post: 2017-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module